Topical glucocorticoids with increased benefit, risk ratio:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Basel [u.a.]
Karger
1993
|
Schriftenreihe: | Current problems in dermatology
21 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | VIII, 207 S. Ill., graph. Darst. |
ISBN: | 3805557124 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV008884866 | ||
003 | DE-604 | ||
005 | 20010807 | ||
007 | t | ||
008 | 940214s1993 ad|| |||| 00||| eng d | ||
020 | |a 3805557124 |9 3-8055-5712-4 | ||
035 | |a (OCoLC)28749493 | ||
035 | |a (DE-599)BVBBV008884866 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-355 |a DE-19 |a DE-578 | ||
050 | 0 | |a RM292.3 | |
082 | 0 | |a 615/.364 |2 20 | |
084 | |a XI 5978 |0 (DE-625)153019:12985 |2 rvk | ||
084 | |a MED 620f |2 stub | ||
084 | |a MED 970f |2 stub | ||
084 | |a CHE 697f |2 stub | ||
245 | 1 | 0 | |a Topical glucocorticoids with increased benefit, risk ratio |c vol. ed. H. C. Korting ... |
264 | 1 | |a Basel [u.a.] |b Karger |c 1993 | |
300 | |a VIII, 207 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Current problems in dermatology |v 21 | |
650 | 4 | |a Administration, Topical | |
650 | 4 | |a Anti-Inflammatory Agents |x pharmacology | |
650 | 4 | |a Anti-Inflammatory Agents |x therapeutic use | |
650 | 4 | |a Dermatopharmacology | |
650 | 4 | |a Glucocorticoids |x Therapeutic use | |
650 | 4 | |a Glucocorticoids |x pharmacology | |
650 | 4 | |a Glucocorticoids |x therapeutic use | |
650 | 4 | |a Transdermal medication | |
650 | 0 | 7 | |a Hautkrankheit |0 (DE-588)4023852-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lokaltherapie |0 (DE-588)4206752-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Glucocorticosteroide |0 (DE-588)4021338-9 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Glucocorticosteroide |0 (DE-588)4021338-9 |D s |
689 | 0 | 1 | |a Lokaltherapie |0 (DE-588)4206752-2 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Glucocorticosteroide |0 (DE-588)4021338-9 |D s |
689 | 1 | 1 | |a Hautkrankheit |0 (DE-588)4023852-0 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Lokaltherapie |0 (DE-588)4206752-2 |D s |
689 | 2 | 1 | |a Glucocorticosteroide |0 (DE-588)4021338-9 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Korting, Hans Christian |d 1952-2012 |e Sonstige |0 (DE-588)130283657 |4 oth | |
830 | 0 | |a Current problems in dermatology |v 21 |w (DE-604)BV002570447 |9 21 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005877778&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-005877778 |
Datensatz im Suchindex
_version_ | 1804123242040918016 |
---|---|
adam_text | TOPICAL GLUCOCORTICOIDS WITH INCREASED BENEFIT/RISK RATIO VOLUME EDITORS
H.C. KORTING, MUNICH H.I. MAIBACH, SAN FRANCISCO, CALIF. 58 FIGURES, 10
COLOR PLATES, 47 TABLES, 1993 1/ A N / * E N BASEL * FREIBURG * PARIS *
LONDON * NEW YORK * L ^ LVVJ CIV NEW DELHI * BANGKOK * SINGAPORE * TOKYO
* SYDNEY CONTENTS PREFACE VII PRINCIPAL CONSIDERATIONS DO WE NEED NEW
AND DIFFERENT GLUCOCORTICOIDS? A RE-APPRAISAL OF THE VARIOUS CONGENERS
AND POTENTIAL ALTERNATIVES 1 SMITH, E.W. (GRAHAMSTOWN) DESIGN OF NOVEL
SOFT CORTICOSTEROIDS 11 BODOR, N. (GAINESVILLE, FLA.) BASIC
PHARMACOLOGIC CONSIDERATIONS GLUCOCORTICOID RECEPTORS 20 PONEC, M.
(LEIDEN) METHODS OF COMPUTER-AIDED DRUG DESIGN AND THEIR APPLICATIONS TO
STEROIDS .... 29 STOUCH, T.R. (PRINCETON, N.J.) PERCUTANEOUS ABSORPTION
OF TOPICAL CORTICOSTEROIDS 45 WESTER, R.C.; MAIBACH, H.I. (SAN
FRANCISCO, CALIF.) METABOLISM OF TOPICAL DRUGS WITHIN THE SKIN, IN
PARTICULAR GLUCOCORTICOIDS 61 KUBOTA, K.; ADEMOLA, J.; MAIBACH, H.I.
(SAN FRANCISCO, CALIF.) INFLUENCE OF GLUCOCORTICOIDS ON THE EPIDERMAL
LANGERHANS CELL 67 MOMMAAS, A.M. (LEIDEN) EFFECT OF GLUCOCORTICOSTEROIDS
ON NUMBER AND FUNCTION OF CONNECTIVE-TISSUE CELLS . 73 HEIN, R.
(REGENSBURG) TOPICAL TRETINOIN PREVENTS CORTICOSTEROID-INDUCED ATROPHY
WITHOUT LESSENING THE ANTI-INFLAMMATORY EFFECT 79 KLIGMAN, L.H.
(PHILADELPHIA, PA.); SCHWARTZ, E. (NEW YORK, N.Y.); LESNIK, R.H.
(PHILADELPHIA, PA.); MEZICK, J.A. (RARITAN, N.J.) APPLIED PHARMACOLOGIC
CONSIDERATIONS RANKING OF TOPICAL GLUCOCORTICOIDS. PRINCIPLES AND
RESULTS 89 SMITH, E.W.; HAIGH, J.M. (GRAHAMSTOWN) SUPPRESSION OF INDUCED
INFLAMMATION IN MAN 97 KERSCHER, M.J. (MUNICH) THE PSORIASIS PLAQUE TEST
AND TOPICAL GLUCOCORTICOIDS: EVALUATION BY COMPUTERIZED LASER
PROFILOMETRY .107 WOLFF, H.H.; KREUSCH, J.F.; WILHELM, K.-P.; KLAUS, S.
(LTIBECK) TOPICAL GLUCOCORTICOIDS AND THINNING OF NORMAL SKIN AS TO BE
ASSESSED BY ULTRASOUND 114 KORTING, H.C. (MUNICH) SIDE EFFECTS OF
TOPICAL GLUCOCORTICOIDS 122 MILLS, CM.; MARKS, R. (CARDIFF) EARLY
DETECTION OF GLUCOCORTICOID-SPECIFIC EPIDERMAL ALTERATIONS USING SKIN
SURFACE MICROSCOPY 132 SCHULZ, H. (BERGKAMEN); NIETSCH, K.H.; HOHLER,
TH. (FRANKFURT/MAIN) INFLUENCE OF GLUCOCORTICOID SUBSTANCES AND THE
VEHICLE ON SKIN IRRITANCY: DETERMINATION BY PROFILOMETRY 140 KORTING,
H.C. (MUNICH) PREDNICARBATE AFTER DIFFERENT FORMS OF ADMINISTRATION.
PLASMA LEVELS OF DRUG AND METABOLITES AND EFFECTS ON ENDOGENOUS CORTISOL
LEVELS IN HUMANS 147 BARTH, J. (BOCHUM); HOCHHAUS, G.; DERENDORF, H.
(GAINESVILLE, FLA.); LEHR, K.H.; HOHLER, TH. (FRANKFURT/MAIN);
MOELLMANN, H. (BOCHUM) CLINICAL CONSIDERATIONS CLINICAL EFFICACY OF
TOPICAL GLUCOCORTICOID PREPARATIONS AND OTHER TYPES OF DERMATICS IN
INFLAMMATORY DISEASES, PARTICULARLY IN ATOPIC DERMATITIS 157 NIEDNER,
R.; SCHOPF, E. (FREIBURG I.BR.) CONTACT ALLERGY TO TOPICAL
GLUCOCORTICOIDS . . . 170 EISNER, P. (ZURICH) ADVERSE DRUG REACTIONS TO
VARIOUS TOPICAL GLUCOCORTICOSTEROIDS: QUANTITATIVE ASPECTS 180 HOHLER,
TH.; WORZ, K.; HIMMLER, V. (FRANKFURT/MAIN) TOPICAL GLUCOCORTICOIDS AND
ANTI-INFECTIVES: A RATIONAL COMBINATION? 186 ZIENICKE, H. (MUNICH)
FUTURE PROSPECTS TOPICAL GLUCOCORTICOIDS: WHAT HAS BEEN ACHIEVED? WHAT
IS STILL TO BE DONE? . . . . 192 SCHAFER-KORTING, M. (FRANKFURT/MAIN)
SUBJECT INDEX 203 CONTENTS VI
|
any_adam_object | 1 |
author_GND | (DE-588)130283657 |
building | Verbundindex |
bvnumber | BV008884866 |
callnumber-first | R - Medicine |
callnumber-label | RM292 |
callnumber-raw | RM292.3 |
callnumber-search | RM292.3 |
callnumber-sort | RM 3292.3 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | XI 5978 |
classification_tum | MED 620f MED 970f CHE 697f |
ctrlnum | (OCoLC)28749493 (DE-599)BVBBV008884866 |
dewey-full | 615/.364 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.364 |
dewey-search | 615/.364 |
dewey-sort | 3615 3364 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02411nam a2200613 cb4500</leader><controlfield tag="001">BV008884866</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20010807 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940214s1993 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805557124</subfield><subfield code="9">3-8055-5712-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28749493</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008884866</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM292.3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.364</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5978</subfield><subfield code="0">(DE-625)153019:12985</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 620f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 970f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 697f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Topical glucocorticoids with increased benefit, risk ratio</subfield><subfield code="c">vol. ed. H. C. Korting ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 207 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Current problems in dermatology</subfield><subfield code="v">21</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Administration, Topical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Inflammatory Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Inflammatory Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dermatopharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glucocorticoids</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glucocorticoids</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glucocorticoids</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transdermal medication</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hautkrankheit</subfield><subfield code="0">(DE-588)4023852-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lokaltherapie</subfield><subfield code="0">(DE-588)4206752-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Glucocorticosteroide</subfield><subfield code="0">(DE-588)4021338-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Glucocorticosteroide</subfield><subfield code="0">(DE-588)4021338-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Lokaltherapie</subfield><subfield code="0">(DE-588)4206752-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Glucocorticosteroide</subfield><subfield code="0">(DE-588)4021338-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Hautkrankheit</subfield><subfield code="0">(DE-588)4023852-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Lokaltherapie</subfield><subfield code="0">(DE-588)4206752-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Glucocorticosteroide</subfield><subfield code="0">(DE-588)4021338-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Korting, Hans Christian</subfield><subfield code="d">1952-2012</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)130283657</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Current problems in dermatology</subfield><subfield code="v">21</subfield><subfield code="w">(DE-604)BV002570447</subfield><subfield code="9">21</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005877778&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005877778</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV008884866 |
illustrated | Illustrated |
indexdate | 2024-07-09T17:26:39Z |
institution | BVB |
isbn | 3805557124 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005877778 |
oclc_num | 28749493 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-578 |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-578 |
physical | VIII, 207 S. Ill., graph. Darst. |
publishDate | 1993 |
publishDateSearch | 1993 |
publishDateSort | 1993 |
publisher | Karger |
record_format | marc |
series | Current problems in dermatology |
series2 | Current problems in dermatology |
spelling | Topical glucocorticoids with increased benefit, risk ratio vol. ed. H. C. Korting ... Basel [u.a.] Karger 1993 VIII, 207 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Current problems in dermatology 21 Administration, Topical Anti-Inflammatory Agents pharmacology Anti-Inflammatory Agents therapeutic use Dermatopharmacology Glucocorticoids Therapeutic use Glucocorticoids pharmacology Glucocorticoids therapeutic use Transdermal medication Hautkrankheit (DE-588)4023852-0 gnd rswk-swf Lokaltherapie (DE-588)4206752-2 gnd rswk-swf Glucocorticosteroide (DE-588)4021338-9 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Glucocorticosteroide (DE-588)4021338-9 s Lokaltherapie (DE-588)4206752-2 s DE-604 Hautkrankheit (DE-588)4023852-0 s Korting, Hans Christian 1952-2012 Sonstige (DE-588)130283657 oth Current problems in dermatology 21 (DE-604)BV002570447 21 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005877778&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Topical glucocorticoids with increased benefit, risk ratio Current problems in dermatology Administration, Topical Anti-Inflammatory Agents pharmacology Anti-Inflammatory Agents therapeutic use Dermatopharmacology Glucocorticoids Therapeutic use Glucocorticoids pharmacology Glucocorticoids therapeutic use Transdermal medication Hautkrankheit (DE-588)4023852-0 gnd Lokaltherapie (DE-588)4206752-2 gnd Glucocorticosteroide (DE-588)4021338-9 gnd |
subject_GND | (DE-588)4023852-0 (DE-588)4206752-2 (DE-588)4021338-9 (DE-588)4143413-4 |
title | Topical glucocorticoids with increased benefit, risk ratio |
title_auth | Topical glucocorticoids with increased benefit, risk ratio |
title_exact_search | Topical glucocorticoids with increased benefit, risk ratio |
title_full | Topical glucocorticoids with increased benefit, risk ratio vol. ed. H. C. Korting ... |
title_fullStr | Topical glucocorticoids with increased benefit, risk ratio vol. ed. H. C. Korting ... |
title_full_unstemmed | Topical glucocorticoids with increased benefit, risk ratio vol. ed. H. C. Korting ... |
title_short | Topical glucocorticoids with increased benefit, risk ratio |
title_sort | topical glucocorticoids with increased benefit risk ratio |
topic | Administration, Topical Anti-Inflammatory Agents pharmacology Anti-Inflammatory Agents therapeutic use Dermatopharmacology Glucocorticoids Therapeutic use Glucocorticoids pharmacology Glucocorticoids therapeutic use Transdermal medication Hautkrankheit (DE-588)4023852-0 gnd Lokaltherapie (DE-588)4206752-2 gnd Glucocorticosteroide (DE-588)4021338-9 gnd |
topic_facet | Administration, Topical Anti-Inflammatory Agents pharmacology Anti-Inflammatory Agents therapeutic use Dermatopharmacology Glucocorticoids Therapeutic use Glucocorticoids pharmacology Glucocorticoids therapeutic use Transdermal medication Hautkrankheit Lokaltherapie Glucocorticosteroide Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005877778&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV002570447 |
work_keys_str_mv | AT kortinghanschristian topicalglucocorticoidswithincreasedbenefitriskratio |